|
|
Volumn 132, Issue 2 II, 1996, Pages 487-495
|
|
Magnesium in acute myocardial infarction: Overview of available evidence
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FIBRINOLYTIC AGENT;
MAGNESIUM;
ACUTE HEART INFARCTION;
CLINICAL TRIAL;
CONFERENCE PAPER;
CORONARY CARE UNIT;
FIBRINOLYTIC THERAPY;
HEALTH CARE COST;
HEART INFARCTION SIZE;
HEART PROTECTION;
HIGH RISK PATIENT;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
NONHUMAN;
PATIENT SELECTION;
PRIORITY JOURNAL;
REPERFUSION INJURY;
RISK BENEFIT ANALYSIS;
THORAX PAIN;
TREATMENT OUTCOME;
|
|
EID: 0029739686
PISSN: 00028703
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-8703(96)90341-5 Document Type: Conference Paper |
|
Times cited : (45)
|
|
References (0)
|
